Enzo Biochem, Inc. (ENZ) Reports Q3 Loss of $0.09/Share
Tweet Send to a FriendGet Alerts ENZ Hot Sheet
Price: $2.28 +1.33%
Revenue Growth %: -11.2%
Financial Fact:
Selling, general, and administrative: 10.89M
Today's EPS Names:
LBIX, ESEA, ISS, More
Revenue Growth %: -11.2%
Financial Fact:
Selling, general, and administrative: 10.89M
Today's EPS Names:
LBIX, ESEA, ISS, More
Trade ENZ Now!
Enzo Biochem, Inc. (NYSE: ENZ) reported Q3 EPS of ($0.09), versus ($0.05) reported last year. Revenue for the quarter came in at $26 million, versus $25.8 million reported last year.
For earnings history and earnings-related data on Enzo Biochem, Inc. (ENZ) click here.
Join StreetInsider.com FREE and get immediately alerted when news breaks on your stocks and other market items - JOIN NOW
*NEW - Download StreetInsider's FREE iPhone and iPad App - Click Here
For earnings history and earnings-related data on Enzo Biochem, Inc. (ENZ) click here.
Join StreetInsider.com FREE and get immediately alerted when news breaks on your stocks and other market items - JOIN NOW
*NEW - Download StreetInsider's FREE iPhone and iPad App - Click Here
You May Also Be Interested In
- UPDATE: Applied Materials, Inc. (AMAT) Tops Q2 EPS by 3c, Offers Guidance
- Macy's (M) Posts Q1 EPS of 55c; Comps Up 3.8%; Boosts Dividend 25%, Raises Buyback
- Kohls Corp. (KSS) Tops Q1 EPS by 8c; Comps Down 1.9%; Guides Q2
Create E-mail Alert Related Categories
EarningsRelated Entities
Earnings
Login with Facebook
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
